C-reactive protein, gamma-glutamyltransferase and type 2 diabetes in a Chinese population.

[1]  O. Franco,et al.  Associations of inflammatory factors with glycaemic status among middle‐aged and older Chinese people , 2009, Clinical endocrinology.

[2]  V. Salomaa,et al.  Association of serum C-reactive protein level with sex-specific type 2 diabetes risk: a prospective finnish study. , 2009, The Journal of clinical endocrinology and metabolism.

[3]  M. Sandhu,et al.  Association of C-reactive protein with type 2 diabetes: prospective analysis and meta-analysis , 2009, Diabetologia.

[4]  D. Friedman,et al.  Prevalence and causes of low vision and blindness in a rural chinese adult population: the Handan Eye Study. , 2008, Ophthalmology.

[5]  J. J. Wang,et al.  Prevalence and Causes of Low Vision and Blindness in a Rural Adult Chinese Population: The Handan Eye Study , 2008 .

[6]  柴田 道彦.  Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men , 2008 .

[7]  L. Chambless,et al.  Sex Differences in the Prediction of Type 2 Diabetes by Inflammatory Markers , 2007, Diabetes Care.

[8]  Theo Stijnen,et al.  Genetic Variation, C-Reactive Protein Levels, and Incidence of Diabetes , 2007, Diabetes.

[9]  S. Kahn,et al.  Review: The role of insulin resistance in nonalcoholic fatty liver disease. , 2006, The Journal of clinical endocrinology and metabolism.

[10]  A. Yamashina,et al.  Elevated serum levels of alanine aminotransferase and gamma glutamyltransferase are markers of inflammation and oxidative stress independent of the metabolic syndrome. , 2006, Atherosclerosis.

[11]  D. Jacobs,et al.  Association between serum gamma-glutamyltransferase and C-reactive protein. , 2005, Atherosclerosis.

[12]  W. Markiewicz,et al.  Association Between Elevated Liver Enzymes and C-Reactive Protein: Possible Hepatic Contribution to Systemic Inflammation in the Metabolic Syndrome , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[13]  D. Jacobs,et al.  γ-Glutamyltransferase, Obesity, and the Risk of Type 2 Diabetes: Observational Cohort Study among 20,158 Middle-Aged Men and Women , 2004 .

[14]  A. Ceriello,et al.  Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[15]  J. Pickup.  Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. , 2004, Diabetes care.

[16]  Masamichi Okubo,et al.  Elevated C-reactive protein is a risk factor for the development of type 2 diabetes in Japanese Americans. , 2003, Diabetes care.

[17]  T. Lam,et al.  C-reactive protein predicts the deterioration of glycemia in chinese subjects with impaired glucose tolerance. , 2003, Diabetes care.

[18]  C. Lewis,et al.  γ-Glutamyltransferase Is a Predictor of Incident Diabetes and Hypertension: The Coronary Artery Risk Development in Young Adults (CARDIA) Study , 2003 .

[19]  J. Pankow,et al.  Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. , 2003, Diabetes.

[20]  T. Funahashi,et al.  Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian. , 2003, Diabetes care.

[21]  D. Jacobs,et al.  Gamma-glutamyltransferase and diabetes—a 4 year follow-up study , 2003, Diabetologia.

[22]  P. Raskin,et al.  Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.

[23]  Zhou Bei‐Fan.  Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults: study on optimal cut‐off points of body mass index and waist circumference in Chinese adults , 2002 .

[24]  N. Sattar,et al.  C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. , 2002, Diabetes.

[25]  S. Haffner,et al.  Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. , 2002, Diabetes.

[26]  J. Manson,et al.  C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. , 2001, JAMA.

[27]  J. Whitfield.  Gamma Glutamyl Transferase , 2001, Critical reviews in clinical laboratory sciences.

[28]  A. Paolicchi,et al.  Gamma-glutamyl transpeptidase-dependent iron reduction and LDL oxidation--a potential mechanism in atherosclerosis. , 1999, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[29]  G. Siest,et al.  gamma-Glutamyltransferase dependent generation of reactive oxygen species from a glutathione/transferrin system. , 1998, Free radical biology & medicine.

[30]  M. A. Crook,et al.  Is Type II diabetes mellitus a disease of the innate immune system? , 1998, Diabetologia.

[31]  S. Wannamethee,et al.  Prospective Study of Serum γ-Glutamyltransferase and Risk of NIDDM , 1998, Diabetes Care.

[32]  P. Heinrich,et al.  Acute‐phase response of human hepatocytes: Regulation of acute‐phase protein synthesis by interleukin‐6 , 1990, Hepatology.